Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Abhijeet Lele Insider Profile
4 Followers
Abhijeet Lele, Director at Agile Therapeutics, holds 37.95K shares in Agile Therapeutics (Ticker: AGRX), holds 2.11M shares in Stereotaxis (Ticker: STXS). Most recently, Abhijeet Lele Bought ― shares of Agile Therapeutics on Apr 01, 2019 for an estimated value of 30.80K.
Abhijeet Lele has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Abhijeet Lele holds in companies
Most Profitable Insider Trade
The most profitable trade made by Abhijeet Lele
Abhijeet Lele's Trading History
Agile Therapeutics
Apr 01, 2019
Director
Informative Buy
30.80K
$103.98K
Stereotaxis
―
Director
―
$9.12M
List of latest transactions for each holding click on a transaction to see Abhijeet Lele's performance on stock
You May Also Like
Abhijeet Lele insider profile FAQ
What is the percentage of profitable transactions made by Abhijeet Lele?
The percentage of profitable transactions made by Abhijeet Lele is ―.
What is the average return per transaction made by Abhijeet Lele?
The average return per transaction made by Abhijeet Lele is ―.
What stocks does Abhijeet Lele hold?
Abhijeet Lele holds: AGRX, STXS stocks.
What was Abhijeet Lele’s latest transaction?
Abhijeet Lele latest transaction was an Informative Buy of $30.80K.
What was Abhijeet Lele's most profitable transaction?
Abhijeet Lele’s most profitable transaction was an Informative Buy of AGRX stock on April 1, 2019. The return on the trade was 25.60%.
What is Abhijeet Lele's role in Agile Therapeutics?
Abhijeet Lele's role in Agile Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.